These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36819776)

  • 1. Identification of Gene Signature-Related Oxidative Stress for Predicting Prognosis of Colorectal Cancer.
    Wang X; Chen L; Cao H; Huang J
    Oxid Med Cell Longev; 2023; 2023():5385742. PubMed ID: 36819776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a novel six-gene signature based on mucinous adenocarcinoma-related gene molecular typing in colorectal cancer.
    Man Y; Xin D; Ji Y; Liu Y; Kou L; Jiang L
    Discov Oncol; 2024 Mar; 15(1):63. PubMed ID: 38443703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy.
    Cui Z; Liu C; Li H; Wang J; Li G
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38415454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
    Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y
    J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel Immune-Related prognostic model for patients with colorectal cancer based on 3 subtypes.
    Yang X; Wei Q
    Immunobiology; 2023 Mar; 228(2):152352. PubMed ID: 36827833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CLRN3-Based CD8
    Gong Z; Huang X; Cao Q; Wu Y; Zhang Q
    Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Treg-related riskscore model may improve the prognosis evaluation of colorectal cancer.
    Li Q; Chu Y; Yao Y; Song Q
    J Gene Med; 2024 Feb; 26(2):e3668. PubMed ID: 38342959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
    Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
    Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
    Wang L; Qu H; Ma X; Liu X
    Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Typing Based on Oxidative Stress Genes and Establishment of Prognostic Characteristics of 7 Genes in Lung Adenocarcinoma.
    Tu J; Tang M; Li G; Chen L; Huang Y
    Oxid Med Cell Longev; 2022; 2022():9683819. PubMed ID: 36148413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer.
    Zhang S; Yang J; Wu H; Cao T; Ji T
    Front Pharmacol; 2023; 14():1091378. PubMed ID: 37138854
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
    Wang H; Wang W; Wang Z; Li X
    Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients.
    Zhang ZJ; Huang YP; Liu ZT; Wang YX; Zhou H; Hou KX; Tang JW; Xiong L; Wen Y; Huang SF
    Front Immunol; 2023; 14():1028404. PubMed ID: 36817485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.